They discovered that individuals hospitalized with COVID-19 who had a history of VTE, a predischarge CRP level more than 10 mg/mL, or a peak D-dimer level greater than 3 g/mL during hospitalization were more likely to develop new VTE after discharge [11]. The gene discussed is CRP; the disease is COVID-19.